WebbSalarius Pharmaceuticals, Inc. Common Stock (SLRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Webb13 apr. 2024 · About SLRX. Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing epigenetic-based cancer treatments. Its lead candidate is Seclidemstat (SP-2577), a small molecular inhibitor which is in Phase I/II clinical trial for the treatment of advanced solid tumors, as well as Ewing sarcoma.
SLRX Salarius Pharmaceuticals Inc. Analyst Estimates & Rating – …
Webb18 aug. 2024 · En warrant är ett hävstångsinstrument där du som innehavare har rätten att antingen köpa eller sälja underliggande tillgång till ett på förhand bestämt pris och en på förhand bestämd lösendag. Den underliggande tillgången kan … WebbThis Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names … campers for 5 ft pickup bed truck
Salarius Announces Exercise Of Warrants For $3.5 Million Of …
Webb25 feb. 2024 · Salarius Pharmaceuticals의 주가, SLRX 주식, 차트, 기술적 분석, 실적 자료 등 Salarius Pharmaceuticals Inc 시세에 대한 자세한 정보를 확인해 보세요. 오늘의 시세뿐만 아니라 뉴스와 분석, 재정 상황, 포럼 등도 확인해 보세요. WebbStock analysis for Salarius Pharmaceuticals Inc (SLRX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Webb24 mars 2024 · SLRX ($2.11) is significantly undervalued by 78.01% relative to our estimate of its Fair Value price of $9.59 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety Significantly Below Fair Value Valuation SLRX is unprofitable, so we... subscribe to Premium to read more. first tech install